Table 2.

Univariate and multivariate analyses of associated with optimal cytoreduction.

Variables		No visible residual disease(n=37)	Visible residual disease(n=81)	Univariate P value	Multivariate P value	Multivariate OR(95%CI)
Age(years)				0.824
≤55		20	42
>55		17	39
FIGO Stage				0.844
III		31	69
IV		6	12
Histology				0.014	0.256	3.491(0.403-30.216)
Serous		36	65
None serous		1	16
CA125U/ml≤1800U/ml presentation	Yes	18	42	0.747
	No	19	39
CA125U/ml≤850U/ml after the 1st NAC*	Yes	19	38	0.526
	No	15	39
Reduction CA125U/ml>30% after the 1st NAC*	Yes	17	42	0.685
	No	17	35
CA125≤200U/ml preoperatively	Yes	29	29	0.000	0.012	3.667(1.337-10.057)
	No	8	52
Reduction CA125U/ml>80% presentation to preop	Yes	28	33	0.000	0.059	2.540(0.965-6.683)
	No	9	48